ロード中...
Use of darbepoetin alfa in the treatment of anaemia of chronic kidney disease: clinical and pharmacoeconomic considerations
The introduction of erythropoiesis-stimulating agents (ESAs) into everyday clinical practice has greatly improved the care of patients with chronic kidney disease. ESAs have reduced the need for blood transfusions, improved survival, decreased cardiovascular complications and enhanced patient qualit...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2638549/ https://ncbi.nlm.nih.gov/pubmed/19461859 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndtplus/sfn175 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|